Development and commercialization of innovative pharmaceutical products for severe and life-threatening bacterial and fungal infections.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: May 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Takeda
B
Development and commercialization of innovative medicines in various therapeutic areas, including gastrointestinal diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.
Debiopharm
B
Drug development and manufacturing, with a focus on cancer and infectious diseases.
Orphan Europe
B
Development and commercialization of drugs for rare diseases.
Initiatives identified among leaders
Certification d’égalité salariale validée par audit indépendant
“Debiopharm a mené une analyse d’équité salariale a...” - DebiopharmDéveloppement de programmes de responsabilité sociale
“Takeda développe des programmes de responsabilité ...” - Takedaprise d'engagement pour la protection de l'environnement et la responsabilité sociétale
“Orphan Europe prend des engagements pour la protec...” - Orphan Europe52% of similar organizations communicate on CSR issues
+846 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports